Abstract
Objective To understand the acceptability of patient-facing mobile robotic systems on a national scale, conduct a pilot feasibility study to deploy and measure satisfaction associated with clinical evaluation using a mobile telehealth robot in the emergency department (ED) and to build a decision analytic model to gauge the potential of a robotic system to prevent COVID-19 infections and conserve personal protective equipment in the ED.
Design Mixed study comprising an online sampling-based survey, single-site observational clinical trial and development of a decision analytic model.
Setting A quaternary care, urban, academic, emergency department in Boston, Massachusetts, USA.
Participants For the acceptability survey, we recruited N=1000 individuals living in the United States participating in an online sampling from the survey provider YouGov. In the ED study, we enrolled 40 individuals over 18 years old presenting to the ED for evaluation.
Interventions In the pilot ED study, consenting participants were exposed to a mobile robotic system facilitated triage interview controlled by an emergency medicine clinician. Afterwards, participants completed a survey to measure their satisfaction with the robotic system.
Main outcome measures Acceptability of mobile robot facilitated tasks in healthcare (national survey), satisfaction with interaction of a robotic system (ED study), number of potential SARS-CoV-2 infections avoided and cost savings (US dollars) per year per ED (decision analytic model).
Results In the national survey, participants rated the use of robotics for a variety of patient-facing healthcare functions useful or very useful. The perceived usefulness increased when asked to consider these functions in the context of the COVID-19 pandemic. In the ED, 40 patients completed study procedures; 92.5% (N=37) reported satisfaction with the robotic system. Most participants (82.5%, N=33) reported their experience being evaluated by a robotic system was as good as an in-person encounter. Our decision analytic model estimated that robotic evaluations could prevent 2.68 infections per ED yearly and save $1 million annually per ED by decreasing PPE and additional staffing in a triage space.
Conclusions Robotic systems were broadly acceptable across the US and their acceptance increased in the setting of COVID-19. Mobile robotic-enabled teleheath facilitated contactless evaluation of ED patients and was highly acceptable and equivalent to an in-person history. Robotic platforms may prevent healthcare-associated COVID-19 transmission to healthcare workers and have a significant cost savings if widely implemented among healthcare systems.
Trial Registration Clinicaltrials.gov, NCT04452695
What is already known on the topic
Mobile robots can provide telemedicine services that enable remote evaluation of patients in various settings.
The use of mobile systems may facilitate contactless evaluation of patients while minimizing use of personal protective equipment (PPE) during the COVID-19 pandemic.
What this study adds
Our study suggests that there is broad acceptability of mobile robotic systems to perform patient-facing tasks in the hospital. This sentiment is reflected in satisfaction of patients in the emergency department interacting with a mobile robotic teletriage system during our open label pilot study.
Our decision analysis model suggests that adoption of robotic systems for teletriage in the emergency department may prevent up to 2.68 SARS-CoV-2 infections among healthcare workers over one year per emergency department in the United States as well as a cost savings in deploying a robotic system compared to a clinician to evaluate patients during the COVID-19 pandemic.
Competing Interest Statement
MD and MR are employees of Boston Dynamics.
Clinical Trial
NCT04452695
Funding Statement
PRC supported by NIH K23DA044874, R44DA051106, Hans and Mavis Lopater Psychosocial Foundation and eink corporation. JNC is supported by NIH T32DK007191. EWB supported by NIH R01DA047236. GT is supported by the Karl van Tassel Career Development Professorship at MIT, the Department of Mechanical Engineering, MIT and Division of Gastroenterology, Brigham and Women's Hospital
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Mass General Brigham Institutional Review (IRB) approval was received prior to initiating the study (MGB 2020P000957).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Solidworks plans for healthcare payloads used on the quadruped robotic system (Boston Dynamics) in this investigation are available at https://github.com/boston-dynamics/bosdyn-hospital-bot. Individual data for the public survey, clinical study and decision analysis model is included as supplemental data to this manuscript.
